Eli Lilly Acquires Obesity Drug Maker Versanis for $1.9B – M&A
by Fred Pennic 07/14/2023 Leave a Comment
Versanis logo
What You Should Know:
Eli Lilly announced an agreement to acquire Versanis, a private clinical-stage biopharmaceutical company focused on the development of new medicines for the treatment of…
Continue Reading